Search clinical trials for: Femara® Tablets 2.5 mg

Total 4355 results

Pain Therapeutics
National Institute on Aging (NIA)

Completed

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Alzheimer Disease

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

Healthy

United States
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 80 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Desmopressin Acetate 0.2 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Fasting Conditions

Healthy

Canada
Ferring Pharmaceuticals

Completed

Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

Infertility, Female

Belgium, Czech Republic, Spain
Bandim Health Project

Completed

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Malaria | Effectiveness

Guinea-Bissau
Takeda

Completed

Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -

Insomnia

Japan
Angiogenix

Unknown

PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
Memorial Sloan Kettering Cancer Center

Completed

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | KRAS Gene Mutation

United States
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Alzheimer Disease

United States
GlaxoSmithKline

Withdrawn

A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

Cancer
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

Fasting State

India
Bayer

Completed

Effect of Riociguat on Bone Metabolism

Pharmacology, Clinical

Germany
University of Tartu

Completed

The Effect of Semaglutide on Pituitary Function

Healthy

Estonia
Mylan Pharmaceuticals Inc

Completed

Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
IntegoGen, LLC

Withdrawn

Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg

Healthy

United States
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fasting

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Healthy

United States
National Taiwan University Hospital
Shin Kong Wu Ho-Su Memorial Hospital

Not yet recruiting

Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease (EMPA-RRED)

Heart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
Bayer
Amgen

Completed

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Carcinoma

United States
Johns Hopkins All Children's Hospital

Terminated

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Central Nervous System Tumors

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy

United States
Boston Scientific Corporation

Completed

Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases (MOTION)

Pain | Neoplasm Metastasis | Bone Metastasis of Diverse Origins

United States, France
Boehringer Ingelheim

Completed

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

Parkinson Disease
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Healthy

United States
Concert Pharmaceuticals

Completed

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

Healthy

United States
Bausch Health Americas, Inc.

Completed

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)

Healthy
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

Healthy

United States
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fed

Healthy

United States
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

Healthy

United States
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, South Africa, Belgium, Croatia, Germany, Poland, Romania, Serbia, Ukraine, United Kingdom, Austria, Czech Republic, Lithuania, Russian Federation
Ardea Biosciences, Inc.

Completed

RDEA3170 Bioavailability Study

Gout

United States
Tulane University School of Medicine
Sanofi; University of Washington; Preventice; Marrek, INC; Mckesson

Terminated

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence (EDORA)

Atrial Fibrillation | Atrial Fibrillation Recurrent

United States
Ayesha De Costa
Boston Children's Hospital; Muhimbili University of Health and Allied Sciences and other collaborators

Completed

Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea Management (ZTDT)

Diarrhea

Tanzania, India
Reata, a wholly owned subsidiary of Biogen
AbbVie

Completed

RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR

MItochondrial Myopathies

United States, Denmark
Pfizer
Pfizer

Recruiting

Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD (PROSPECT)

Sickle Cell Disease

United States
Alfasigma S.p.A.
Parexel

Terminated

Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis (VARIANT)

BACTERIAL VAGINOSIS

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

Healthy

United States

3

Subscribe